로딩 중…
지수 로딩 중…
CJ Bioscience
311690· KOSDAQ· Health Care· Health Care Equipment & Services
₩4,610-3.96%
2026-06-19
Price Chart
CJ Bioscience-50.64%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 60.23B KRW |
| Revenue | 3.56B KRW |
| Net Income | -4.16B KRW |
| Total Assets | 65.09B KRW |
| Net Assets | 48.11B KRW |
| Employees | 129 |
| Value | |
| P/B | 1.25x |
| P/S | 16.91x |
| FCF Yield | -38.89% |
| Profitability | |
| ROE | -8.65% |
| ROA | -6.39% |
| Op. Margin | -660.47% |
| Revenue Growth | -14.22% |
| Financial Health | |
| Debt Ratio | 135.29% |
| Total Debt | 7.50B KRW |
| FCF | -23.43B KRW |
| Cash | 2.13B KRW |
| Current Ratio | 3.54x |
| Performance | |
| 1Y Return | -50.64% |
| 1M Return | -23.93% |
| From 52W High | -62.52% |
| 1Y MDD | -60.71% |
| Trading | |
| Volume | 13,520 shares |
| Foreign Own. | 2.73% |
| Per Share | |
| EPS | -1,761 KRW |
| BPS | 3,682 KRW |
Company Info
CJ Bioscience, a microbiome specialized company, was established in 2009 and listed on the KOSDAQ market in 2019. The company engages in therapeutic new drug development via its Artificial Intelligence-based microbiome big data platform, bioinformatics analysis services, and customized healthcare solutions. It offers new drug candidate material analysis based on the Ez-Mx® platform, microbial genome analysis utilizing EzBioCloud and N integrated solutions, and customized healthcare services leveraging a human microbiome database of over 140,000 cases. CJ Bioscience is headquartered in Jung-gu, Seoul.